Pollen and mold exposure impairs the work performance of employees with allergic rhinitis

Ronald C. Kessler, David Almeida, Patricia Berglund, Paul Stang

Research output: Contribution to journalArticle

58 Citations (Scopus)

Abstract

Background: Although quality of life studies suggest that allergic rhinitis has a substantial impact on work impairment, national survey estimates of the magnitude of this impairment have varied widely. Retrospective recall bias is likely to be a major cause of this variability. Objective: This study used a nationally representative daily diary sample to obtain prospective data that improve on previous estimates of the work impairment because of allergic rhinitis. Methods: The MacArthur Foundation National Survey of Daily Experience is a daily diary survey that included a nationally representative subsample of 739 employed people, each of whom provided daily reports on work performance for 1 randomly assigned week of the calendar year. National Allergy Bureau monitoring station data were merged with the survey data to study the association of time-space variation in pollen/mold exposure with impaired daily work quality and quantity. Results: National Allergy Bureau pollen/mold counts are significantly related to work impairments only among respondents with self-reported allergic rhinitis. The average estimated monthly salary -equivalent work impairment costs associated with pollen/mold exposure for each allergy sufferer is between $109 and $156, with an annualized national projection of between $5.4 billion and $7.7 billion. Conclusions: The extent to which these costs can be recovered by increasing the proportion of allergy sufferers who are successfully treated remains unknown and can only be evaluated definitively in effectiveness trials.

Original languageEnglish (US)
Pages (from-to)289-295
Number of pages7
JournalAnnals of Allergy, Asthma and Immunology
Volume87
Issue number4
DOIs
StatePublished - Jan 1 2001

Fingerprint

Pollen
Fungi
Hypersensitivity
Costs and Cost Analysis
Seasonal Allergic Rhinitis
Salaries and Fringe Benefits
Quality of Life
Surveys and Questionnaires
Work Performance
Allergic Rhinitis

All Science Journal Classification (ASJC) codes

  • Immunology and Allergy
  • Pulmonary and Respiratory Medicine

Cite this

Kessler, Ronald C. ; Almeida, David ; Berglund, Patricia ; Stang, Paul. / Pollen and mold exposure impairs the work performance of employees with allergic rhinitis. In: Annals of Allergy, Asthma and Immunology. 2001 ; Vol. 87, No. 4. pp. 289-295.
@article{22e934a57f7e466499c3ebe24cb9895e,
title = "Pollen and mold exposure impairs the work performance of employees with allergic rhinitis",
abstract = "Background: Although quality of life studies suggest that allergic rhinitis has a substantial impact on work impairment, national survey estimates of the magnitude of this impairment have varied widely. Retrospective recall bias is likely to be a major cause of this variability. Objective: This study used a nationally representative daily diary sample to obtain prospective data that improve on previous estimates of the work impairment because of allergic rhinitis. Methods: The MacArthur Foundation National Survey of Daily Experience is a daily diary survey that included a nationally representative subsample of 739 employed people, each of whom provided daily reports on work performance for 1 randomly assigned week of the calendar year. National Allergy Bureau monitoring station data were merged with the survey data to study the association of time-space variation in pollen/mold exposure with impaired daily work quality and quantity. Results: National Allergy Bureau pollen/mold counts are significantly related to work impairments only among respondents with self-reported allergic rhinitis. The average estimated monthly salary -equivalent work impairment costs associated with pollen/mold exposure for each allergy sufferer is between $109 and $156, with an annualized national projection of between $5.4 billion and $7.7 billion. Conclusions: The extent to which these costs can be recovered by increasing the proportion of allergy sufferers who are successfully treated remains unknown and can only be evaluated definitively in effectiveness trials.",
author = "Kessler, {Ronald C.} and David Almeida and Patricia Berglund and Paul Stang",
year = "2001",
month = "1",
day = "1",
doi = "10.1016/S1081-1206(10)62242-9",
language = "English (US)",
volume = "87",
pages = "289--295",
journal = "Annals of Allergy, Asthma and Immunology",
issn = "1081-1206",
publisher = "American College of Allergy, Asthma and Immunology",
number = "4",

}

Pollen and mold exposure impairs the work performance of employees with allergic rhinitis. / Kessler, Ronald C.; Almeida, David; Berglund, Patricia; Stang, Paul.

In: Annals of Allergy, Asthma and Immunology, Vol. 87, No. 4, 01.01.2001, p. 289-295.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Pollen and mold exposure impairs the work performance of employees with allergic rhinitis

AU - Kessler, Ronald C.

AU - Almeida, David

AU - Berglund, Patricia

AU - Stang, Paul

PY - 2001/1/1

Y1 - 2001/1/1

N2 - Background: Although quality of life studies suggest that allergic rhinitis has a substantial impact on work impairment, national survey estimates of the magnitude of this impairment have varied widely. Retrospective recall bias is likely to be a major cause of this variability. Objective: This study used a nationally representative daily diary sample to obtain prospective data that improve on previous estimates of the work impairment because of allergic rhinitis. Methods: The MacArthur Foundation National Survey of Daily Experience is a daily diary survey that included a nationally representative subsample of 739 employed people, each of whom provided daily reports on work performance for 1 randomly assigned week of the calendar year. National Allergy Bureau monitoring station data were merged with the survey data to study the association of time-space variation in pollen/mold exposure with impaired daily work quality and quantity. Results: National Allergy Bureau pollen/mold counts are significantly related to work impairments only among respondents with self-reported allergic rhinitis. The average estimated monthly salary -equivalent work impairment costs associated with pollen/mold exposure for each allergy sufferer is between $109 and $156, with an annualized national projection of between $5.4 billion and $7.7 billion. Conclusions: The extent to which these costs can be recovered by increasing the proportion of allergy sufferers who are successfully treated remains unknown and can only be evaluated definitively in effectiveness trials.

AB - Background: Although quality of life studies suggest that allergic rhinitis has a substantial impact on work impairment, national survey estimates of the magnitude of this impairment have varied widely. Retrospective recall bias is likely to be a major cause of this variability. Objective: This study used a nationally representative daily diary sample to obtain prospective data that improve on previous estimates of the work impairment because of allergic rhinitis. Methods: The MacArthur Foundation National Survey of Daily Experience is a daily diary survey that included a nationally representative subsample of 739 employed people, each of whom provided daily reports on work performance for 1 randomly assigned week of the calendar year. National Allergy Bureau monitoring station data were merged with the survey data to study the association of time-space variation in pollen/mold exposure with impaired daily work quality and quantity. Results: National Allergy Bureau pollen/mold counts are significantly related to work impairments only among respondents with self-reported allergic rhinitis. The average estimated monthly salary -equivalent work impairment costs associated with pollen/mold exposure for each allergy sufferer is between $109 and $156, with an annualized national projection of between $5.4 billion and $7.7 billion. Conclusions: The extent to which these costs can be recovered by increasing the proportion of allergy sufferers who are successfully treated remains unknown and can only be evaluated definitively in effectiveness trials.

UR - http://www.scopus.com/inward/record.url?scp=0034768646&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034768646&partnerID=8YFLogxK

U2 - 10.1016/S1081-1206(10)62242-9

DO - 10.1016/S1081-1206(10)62242-9

M3 - Article

VL - 87

SP - 289

EP - 295

JO - Annals of Allergy, Asthma and Immunology

JF - Annals of Allergy, Asthma and Immunology

SN - 1081-1206

IS - 4

ER -